The EANM Young Scientist Network (YSN) is a new competitive research award developed by EANM with the generous support of Advanced Accelerator Applications (ADACAP), a Novartis company.
The YSN aims to support early-career physician scientists and researchers conducting innovative research in alpha radioligand therapy (α-RLT). By fostering promising small to mid-size projects, the YSN seeks to accelerate high-quality research with clear translational and clinical relevance.
The award will be launched at the EANM’26 Congress with a dedicated 90-minute session featuring presentations of selected projects, the announcement of award winners, and, from the second year onward, follow-up on previous awardees. The YSN will be hosted annually at the EANM Annual Congress to ensure continuity and long-term visibility.
Submission deadline: Monday, May 18, 2026 (23:59 CEST)